Neuromod Devices Appoints Joe Ghiz as Chief Commercial Officer
Neuromod Devices names former Align Technology executive Joe Ghiz as Chief Commercial Officer to drive global expansion for its tinnitus treatment device,…
Neuromod Devices names former Align Technology executive Joe Ghiz as Chief Commercial Officer to drive global expansion for its tinnitus treatment device,…
Oura eyes a $2.2 billion IPO on the Nasdaq, balancing rapid revenue growth and strategic partnerships with medical device firms against ongoing…
Kestra Medical posts 60% revenue growth and lifts long-term margin guidance, fueled by strong adoption of its cardiac recovery system and expanding…
Cooper Companies stock faces heavy selling pressure after a disappointing Q3 sales report and a downward revision to annual guidance, driven by…
Oura prepares for an IPO with a $60.8 million profit, balancing retail partnerships with Amazon and Best Buy against regulatory scrutiny and…
Medtronic exceeded Q1 expectations with 13.7% organic growth, bolstered by strong demand in its core cardiac and surgical businesses and strategic expansion…
MiniMed delivered 16% organic growth in Q1 2027, driven by the successful U.S. rollout of the MiniMed Flex pump and expanded international…
Swiss dental startup vVardis, with its drill-free carie treatment, plans a U.S. IPO, signaling market confidence in dental tech innovations.